Methenamine Mandelate
Medicare prescription drug cost, prescriptions and prescribers, 2024
$632K
Medicare cost, 2024
$632K
Medicare cost, 2024
Medicare drug plans spent $632,066 on Methenamine Mandelate in 2024, for 5,946 prescriptions and refills filled by 1,836 patients. Spending fell 20% from 2023 to 2024. California accounts for the most spending ($69,976, 11% of the total).
Medicare cost, 2024
$632K
-19.6% from 2023
Prescriptions
5,946
$106.30 per claim
Patients
1,836
1,750 prescribers
Total spending, 2024
$633K
$344.62 per patient
Questions and answers
How much does Medicare spend on Methenamine Mandelate?
Medicare prescription drug plans paid $632K for Methenamine Mandelate in 2024, for 5,946 prescriptions and refills to 1,836 patients (down 19.6% from 2023). The average cost per claim was $106.30.
Which state spends the most on Methenamine Mandelate?
California had the highest Medicare cost for Methenamine Mandelate in 2024: $70K for 612 claims, followed by Pennsylvania ($64K).
Who prescribes Methenamine Mandelate the most?
Sandra L Lindholm-Norman, nurse practitioner in Walnut Creek, CA, had the highest Medicare cost for Methenamine Mandelate in 2024: 12 claims costing $6,492.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Methenamine Mandelate was $633K in 2024, after a high of $997K in 2020.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Methenamine Mandelate, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Sandra L Lindholm-Norman Walnut Creek, CA | Nurse Practitioner | 12 | Under 11 | $6,492 |
| William A Morton Waycross, GA | Internal Medicine | 95 | Under 11 | $3,639 |
| Surinder Pal Ardsley, NY | Internal Medicine | 12 | Under 11 | $2,798 |
| Paul D Mumma Crooksville, OH | Family Practice | 11 | Under 11 | $2,708 |
| Michael R Evankovich Erie, PA | Urology | 24 | Under 11 | $2,676 |
| Frank J Costa Monroeville, PA | Urology | 15 | Under 11 | $2,463 |
| Jose A Rivera Sepulveda Statesboro, GA | Internal Medicine | 44 | Under 11 | $2,396 |
| Akkil Ali Tamarac, FL | Internal Medicine | 15 | Under 11 | $2,368 |
| Nicholas J Modjeski Winona, MN | Family Practice | 13 | Under 11 | $2,349 |
| Ali Salem Montclair, CA | Internal Medicine | 14 | Under 11 | $2,274 |
| Amanda R Roberts Portland, ME | Internal Medicine | 15 | Under 11 | $2,208 |
| Craig W Canfield San Luis Obispo, CA | Urology | 13 | Under 11 | $2,167 |
| Caroline McWilliams Mays Landing, NJ | Internal Medicine | 34 | Under 11 | $2,150 |
| David C Lesseski Fairview, PA | Family Practice | 17 | Under 11 | $2,132 |
| Jill G Bryant Waycross, GA | Internal Medicine | 26 | Under 11 | $2,045 |
| Nicole R Caniglia Tucson, AZ | Physician Assistant | 13 | Under 11 | $1,994 |
| Austin J Lee Portland, OR | Student in an Organized Health Care Education/Training Program | 13 | Under 11 | $1,994 |
| Jennifer Simmons Bloomsburg, PA | Urology | 15 | Under 11 | $1,971 |
| Margaret E Hagan Wichita, KS | Infectious Disease | 12 | Under 11 | $1,940 |
| Manuel A Ojeda Miami Beach, FL | Internal Medicine | 18 | Under 11 | $1,894 |
| James A Wright Fond Du Lac, WI | Urology | 16 | Under 11 | $1,876 |
| Dhimantkumar A Pandya Mount Kisco, NY | Internal Medicine | 11 | Under 11 | $1,822 |
| William Y Josephson Northridge, CA | Internal Medicine | 14 | Under 11 | $1,800 |
| Margaret M Bismarck Medford, OR | Nurse Practitioner | 11 | Under 11 | $1,795 |
| Michael A Ahearn Kewanee, IL | Hospitalist | 19 | Under 11 | $1,697 |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 2,060 | 7,946 | 2,244 | $785K |
| 2023 | 2,267 | 9,110 | 2,481 | $786K |
| 2024 | 1,750 | 5,946 | 1,836 | $632K |
Makers, 2024
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Chartwell Rx Ll | 3,163 | $364K |
| Edenbridge/Dexc | 2,672 | $259K |
| Seton Pharmaceu | 120 | $10K |
Medicaid spending by quarter
Amount reimbursed by state Medicaid programs, all states
Amount reimbursed
Codes
- National drug codes (packages)
- 15
- RxNorm concept IDs
- 2741045, 992153, 992184
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through July 2026, 187 side-effect reports named methenamine mandelate (reports from 2004 on). 119 of them (63.6%) were serious, 15 named a death and 63 named a hospital stay. The reactions named most often were urinary tract infection, fatigue and asthenia. 92 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
187
20 in 2025 (+33.3% from 2024)
Serious
63.6%
119 reports
Deaths named
15
8.0% of reports
Hospital stays
63
33.7% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Methenamine Mandelate?
187 reports from 2004 through July 2026 named methenamine mandelate. 119 of them (63.6%) were serious, 15 named a death and 63 named a hospital stay.
What are the most reported side effects of Methenamine Mandelate?
30 reports named urinary tract infection, the reaction named most often, followed by fatigue (21) and asthenia (19). In the last 5 years the reaction named most often was urinary tract infection (16 reports). A report can name several reactions.
How many side-effect reports named Methenamine Mandelate in 2025?
20 reports were received in 2025 (+33.3% from 2024). 2026 so far: 12 reports through July 2026, and more keep arriving late.
Do side-effect reports prove that Methenamine Mandelate caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Methenamine Mandelate caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
Side-effect reports from official public data, counted per active ingredient (methenamine mandelate) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.